Harm Westdorp
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 13
- Cancer survivorship and care 3
- Cutaneous Melanoma Detection and Management 2
- Immunology 14
- Immunotherapy and Immune Responses 13
- Co-authors
- I. Jolanda M. de Vries (17 shared papers)Gerty Schreibelt (13 shared papers)Winald R. Gerritsen (18 shared papers)Niven Mehra (12 shared papers)Sandra Heskamp (3 shared papers)Carl Gustav Figdor (10 shared papers)James Nagarajah (6 shared papers)Bastiaan M. Privé (5 shared papers)
- Journals
- Annals of Oncology (6 papers)Frontiers in Immunology (5 papers)Frontiers in Oncology (2 papers)Clinical Cancer Research (2 papers)OncoImmunology (2 papers)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Harm Westdorp
47 papers receiving 1.2k citations
Harm Westdorp's Hit Papers
Peers
Comparison fields: 5 of 60
- Immunology 429
- Oncology 378
- Radiology, Nuclear Medicine and Imaging 212
- Pulmonary and Respiratory Medicine 127
- Ophthalmology 38
Countries citing papers authored by Harm Westdorp
This map shows the geographic impact of Harm Westdorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Westdorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Westdorp more than expected).
Fields of papers citing papers by Harm Westdorp
This network shows the impact of papers produced by Harm Westdorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Westdorp. The network helps show where Harm Westdorp may publish in the future.
Co-authors
The 25 scholars most cited alongside Harm Westdorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 205 | |
| 2 | Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies Hit paper breakdown → | 2023 | 138 |
| 3 | 2019 | 99 | |
| 4 | 2014 | 76 | |
| 5 | 2016 | 75 | |
| 6 | 2022 | 57 | |
| 7 | 2020 | 52 | |
| 8 | 2017 | 49 | |
| 9 | 2016 | 43 | |
| 10 | 2021 | 37 | |
| 11 | 2018 | 34 | |
| 12 | 2021 | 32 | |
| 13 | 2016 | 31 | |
| 14 | 2021 | 26 | |
| 15 | 2024 | 26 | |
| 16 | 2018 | 23 | |
| 17 | 2023 | 23 | |
| 18 | 2016 | 22 | |
| 19 | 2016 | 19 | |
| 20 | 2023 | 19 |
About Harm Westdorp
Harm Westdorp is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (13 papers), Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Cancer survivorship and care (3 papers), Genetic factors in colorectal cancer (3 papers), BRCA gene mutations in cancer (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Immunology (429 citations), Oncology (378 citations), Radiology, Nuclear Medicine and Imaging (212 citations), Pulmonary and Respiratory Medicine (127 citations) and Ophthalmology (38 citations). Harm Westdorp has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include I. Jolanda M. de Vries, Gerty Schreibelt, Winald R. Gerritsen, Niven Mehra, Sandra Heskamp, Carl Gustav Figdor, James Nagarajah, Bastiaan M. Privé, Nicoline Hoogerbrugge and Willemijn AM van Gemert. Their work appears in journals such as Annals of Oncology, Frontiers in Immunology, Frontiers in Oncology, Clinical Cancer Research and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.